Company Filing History:
1 out of 3,221 
1 out of 39 
Years Active: 2021
Title: Juliann Chmielecki: Innovator in Cancer Diagnosis and Treatment
Introduction
Juliann Chmielecki is a prominent inventor based in Medford, MA (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer through innovative methods. Her work focuses on the NRF2 gene and its implications in cancer pathology.
Latest Patents
Juliann holds 1 patent for her invention titled "Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes." This invention provides methods for identifying subjects with cancer, such as lung cancer, by analyzing the expression levels of NRF2 splice variants or target genes. Additionally, it outlines treatment methods using NRF2 pathway antagonists for subjects expressing these variants or overexpressing target genes.
Career Highlights
Throughout her career, Juliann has worked with notable companies in the biotechnology sector, including Genentech, Inc. and Foundation Medicine, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Juliann has collaborated with esteemed colleagues in her field, including Christiaan Nicolaas Klijn and James M Lee. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Juliann Chmielecki's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. Her contributions through her patent and collaborations highlight her commitment to advancing medical science.